Actieve functies van Chengwen Li
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
GeneVentiv Therapeutics, Inc.
GeneVentiv Therapeutics, Inc. BiotechnologyHealth Technology GeneVentiv Therapeutics, Inc. is a company that is developing the first gene therapy for patients with hemophilia A or B, with or without inhibitors. The company is based in Raleigh, NC. The company's product, Genv-Hem, produces clotting factor Va, which allows for normal clotting in response to injury. Currently, there are no curative gene therapies available for patients with inhibitors. GeneVentiv Therapeutics was founded by Chengwen Li and the CEO is Damon R Race. | Oprichter | - | - |
Corporate Officer/Principal | - | - | |
Nabgen, Inc. | Directeur/Bestuurslid | - | - |
Loopbaan van Chengwen Li
Statistieken
Internationaal
Verenigde Staten | 3 |
Operationeel
Founder | 1 |
Corporate Officer/Principal | 1 |
Director/Board Member | 1 |
Sectoraal
Health Technology | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Bedrijven in privébezit | 2 |
---|---|
GeneVentiv Therapeutics, Inc.
GeneVentiv Therapeutics, Inc. BiotechnologyHealth Technology GeneVentiv Therapeutics, Inc. is a company that is developing the first gene therapy for patients with hemophilia A or B, with or without inhibitors. The company is based in Raleigh, NC. The company's product, Genv-Hem, produces clotting factor Va, which allows for normal clotting in response to injury. Currently, there are no curative gene therapies available for patients with inhibitors. GeneVentiv Therapeutics was founded by Chengwen Li and the CEO is Damon R Race. | Health Technology |
Nabgen, Inc. |
- Beurs
- Insiders
- Chengwen Li
- Ervaring